Meisam Akrami | Immunology and Microbiology | Young Scientist Award

Young Scientist Award

Meisam Akrami
Islamic Azad University, Iran

Meisam Akrami
Affiliation Islamic Azad University
Country Iran
Scopus ID 59564669800
Documents 6
Citations 4
h-index 1
Subject Area Immunology and Microbiology
Event International Academic Excellence Awards
ORCID 0000-0002-9075-8397

Meisam Akrami is an academic researcher affiliated with Islamic Azad University, Iran, whose research profile is associated with the field of immunology and microbiology. His scholarly record includes publications addressing microbiological applications, immunological mechanisms, vaccine-related research, diagnostic methodologies and biological processes. His academic profile provides a basis for evaluating his research contributions and potential for recognition through the Young Scientist Award at the International Academic Excellence Awards.

Abstract

Meisam Akrami’s academic profile reflects research activity in microbiology and related biomedical disciplines. The supplied publication record encompasses investigations into bacterial surface-associated antigens, probiotic microorganisms, immunological responses, diagnostic testing and protein purification. These subjects represent important areas of contemporary biomedical research, particularly in infectious disease prevention, laboratory diagnostics and applied microbiology. His documented Scopus profile lists six documents, four citations and an h-index of one. This article presents his academic background, publication themes and potential suitability for early-career research recognition. [1]

Keywords

Meisam Akrami, Young Scientist Award, Immunology, Microbiology, Vaccine Research, Probiotics, Bacterial Antigens, Biomedical Research, Scientific Publications; Research Excellence.

Introduction

Immunology and microbiology contribute substantially to understanding infectious diseases, host–microorganism interactions and the development of preventive healthcare strategies. Research in these disciplines combines experimental investigation, molecular analysis and diagnostic evaluation. Akrami’s listed scholarly work covers several of these interconnected themes, including bacterial immunogenicity, probiotic interactions and laboratory-based disease detection. His institutional affiliation and researcher identifiers provide reference points for examining his academic record. [1] [2]

Research Profile

Akrami is affiliated with Islamic Azad University in Iran. His research classification is associated with Immunology and Microbiology. According to the supplied bibliometric information, his Scopus record contains six documents, four citations and an h-index of one. These indicators provide quantitative information about publication activity and citation performance but do not independently measure research quality, originality or broader academic contributions. His ORCID identifier, 0000-0002-9075-8397, offers an additional mechanism for distinguishing his scholarly identity. [1] [2]

Research Contributions

  • Vaccine development: investigation of a PapG–AcmA surface-associated antigen displayed on Lactobacillus reuteri as a potential vaccine strategy against uropathogenic Escherichia coli. [3]
  • Immunological responses: examination of IL-10 secretion in THP-1 cells following exposure to probiotic bacterial species. [4]
  • Diagnostic microbiology: evaluation of an ELISA kit for bovine brucellosis diagnosis and comparison with established testing approaches. [5]
  • Biotechnology: investigation of purification approaches for diphtheria toxoid production. [6]

Publications

  1. Development of a PapG–AcmA surface-associated antigen on Lactobacillus reuteri as a vaccine strategy against uropathogenic Escherichia coli. Archives of Microbiology, 2026. DOI: 10.1007/s00203-026-05214-9.
  2. A Structurally Interpretable ElasticNet-Based Epigenetic Clock Reveals Distributed and Individualized Architecture of Human Biological Aging. Journal of Molecular Evolution, 2026. DOI: 10.1007/s00239-026-10365-w.
  3. Evaluation of the sensitivity and specificity of a domestically produced ELISA kit for the diagnosis of bovine brucellosis and its comparison with common serological and molecular tests. Comparative Clinical Pathology, 2026. DOI: 10.1007/s00580-026-03875-y.
  4. Viability-Dependent and Structural Modulation of IL-10 Secretion in THP-1 Cells by Lactobacillus gasseri and Lacticaseibacillus rhamnosus. Probiotics and Antimicrobial Proteins, 2026. DOI: 10.1007/s12602-026-11257-7.
  5. Comparing the purification of diphtheria toxoid by different gel filtration columns for large-scale preparation. Journal of Proteins and Proteomics, 2026. DOI: 10.1007/s42485-026-00218-x.

Research Impact

The reported four citations and h-index of one indicate an emerging citation record. The publication themes address subjects with potential relevance to infectious disease research, diagnostic development and biotechnology. In particular, research concerning bacterial antigens and probiotic-associated immune responses contributes to areas of continuing scientific investigation. Citation indicators should be considered alongside methodological quality, individual authorship contributions, reproducibility and the practical significance of published findings. [1]

Award Suitability

The Young Scientist Award, presented within the International Academic Excellence Awards framework, recognizes research activity and scholarly contributions by emerging researchers. Akrami’s documented institutional affiliation, publication record and research interests provide relevant information for consideration under this category. His work across microbiology, immunological investigations and diagnostic research offers several potential evaluation areas. Final recognition should be determined through the award programme’s eligibility requirements, publication verification and independent assessment of research contributions.

Conclusion

Meisam Akrami’s academic profile represents research activity spanning immunology, microbiology and related biomedical applications. His listed publications address vaccine strategies, probiotic interactions, diagnostic testing and biotechnology. Supported by institutional and researcher-profile information, this record provides a foundation for evaluating his academic development and potential eligibility for the Young Scientist Award at the International Academic Excellence Awards. Continued research, publication development and independent validation of scientific contributions will remain important measures of his academic progression.

References

  1. Elsevier. (n.d.). Scopus author details: Meisam Akrami, Author ID 59564669800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59564669800
  2. ORCID. (n.d.). Meisam Akrami – Researcher Identifier.
    https://orcid.org/0000-0002-9075-8397
  3. Springer Nature. (2026). Development of a PapG–AcmA surface-associated antigen on Lactobacillus reuteri as a vaccine strategy against uropathogenic Escherichia coli. Archives of Microbiology.
    https://doi.org/10.1007/s00203-026-05214-9
  4. Springer Nature. (2026). Viability-Dependent and Structural Modulation of IL-10 Secretion in THP-1 Cells by Lactobacillus gasseri and Lacticaseibacillus rhamnosus. Probiotics and Antimicrobial Proteins.
    https://doi.org/10.1007/s12602-026-11257-7
  5. Springer Nature. (2026). Evaluation of the sensitivity and specificity of a domestically produced ELISA kit for the diagnosis of bovine brucellosis and its comparison with common serological and molecular tests. Comparative Clinical Pathology.
    https://doi.org/10.1007/s00580-026-03875-y
  6. Springer Nature. (2026). Comparing the purification of diphtheria toxoid by different gel filtration columns for large-scale preparation. Journal of Proteins and Proteomics.
    https://doi.org/10.1007/s42485-026-00218-x
  7. Springer Nature. (2026). A Structurally Interpretable ElasticNet-Based Epigenetic Clock Reveals Distributed and Individualized Architecture of Human Biological Aging. Journal of Molecular Evolution.
    https://doi.org/10.1007/s00239-026-10365-w

Pourya Gholizadeh | Immunology and Microbiology | Editorial Board Member

Editorial Board Member

Pourya Gholizadeh
Ardabil University of Medical Sciences,Iran

Pourya Gholizadeh
Affiliation Ardabil University of Medical Sciences
Country Iran
Google Scholar ID 1XSHxVkAAAAJ
Documents 110
Citations 4,556
h-index 37
Subject area Immunology and Microbiology
Event International Academic Excellence Awards

Pourya Gholizadeh is a researcher whose listed publications address antimicrobial resistance, microbial pathogenesis, oral microbiology, and the interactions between microorganisms and human health. His work, as represented by the publications supplied for this profile, connects microbiological mechanisms with clinically relevant questions, including antibiotic resistance and the potential contribution of oral bacteria to disease. This article summarizes selected research themes and publications and presents a profile for academic recognition through the International Academic Excellence Awards. The bibliographic details and research metrics should be checked against their original databases before formal publication.[1]

Abstract

This profile reviews selected research by Pourya Gholizadeh in immunology and microbiology. The supplied publication list highlights antibiotic resistance, the CRISPR-Cas system, oral microbial communities, and bacterial contributions to disease. These topics are relevant to infection prevention, antimicrobial stewardship, and the development of future research strategies. The profile uses the provided bibliographic records and metrics without independently verifying database totals or claiming that individual studies establish clinical effectiveness.

Keywords

Antimicrobial resistance; colistin resistance; Enterobacteriaceae; CRISPR-Cas; oral microbiome; microbial pathogenesis; oral cancer; immunology; microbiology; bacterial infection.

Introduction

Antimicrobial resistance is a major research concern because resistant microorganisms can complicate infection management and limit treatment options. In parallel, investigations of the oral microbiome examine how microbial communities interact with host tissues and how particular organisms may be associated with inflammatory conditions and cancer. Gholizadeh’s listed publications address both areas, providing a basis for examining links between microbiological mechanisms and human health.[2]

Research Profile

The supplied records indicate a research portfolio spanning reviews, mechanistic investigations, and discussions of emerging antimicrobial technologies. Its interdisciplinary character is reflected in the relationship between microbial genetics, clinical microbiology, oral health, and infection research. The stated institutional affiliation is Ardabil University of Medical Sciences, Iran. A verified Scopus identifier and ORCID have not been supplied and should be added only after confirmation.

Research Contributions

One prominent theme is colistin resistance in Enterobacteriaceae, a subject relevant to the study of treatment options for difficult bacterial infections. Another is the possible relationship between oral microbial communities and oral cancers. The supplied publication list also includes work discussing Fusobacterium nucleatum in carcinogenesis and the potential use of CRISPR-Cas approaches to address antimicrobial resistance. These publications represent complementary perspectives on resistance mechanisms, microbial-host interactions, and emerging research strategies.[3]

  • Antibiotic resistance mechanisms and colistin resistance.
  • Oral microbiome research and potential disease associations.
  • CRISPR-Cas systems as a prospective research direction for antimicrobial resistance.

Publications

The following selected works are based on the bibliographic information supplied for this article. Citation counts can vary between databases and over time.

  1. Aghapour, Z., Gholizadeh, P., Ganbarov, K., et al. (2019). Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infection and Drug Resistance, 965–975.
  2. Gholizadeh, P., Eslami, H., Yousefi, M., et al. (2016). Role of oral microbiome on oral cancers, a review. Biomedicine & Pharmacotherapy, 84, 552–558.
  3. Gholizadeh, P., Eslami, H., & Kafil, H. S. (2017). Carcinogenesis mechanisms of Fusobacterium nucleatum. Biomedicine & Pharmacotherapy, 89, 918–925.
  4. Gholizadeh, P., Köse, Ş., Dao, S., et al. (2020). How CRISPR-Cas system could be used to combat antimicrobial resistance. Infection and Drug Resistance, 1111–1121.
  5. Gholizadeh, P., Pormohammad, A., Eslami, H., et al. (2017). Oral pathogenesis of Aggregatibacter actinomycetemcomitans. Microbial Pathogenesis, 113, 303–311.

Research Impact

The supplied profile figures report 110 documents, 4,556 citations, and an h-index of 37. These figures suggest a substantial publication and citation record if confirmed against the relevant database profile. They should be treated as user-provided values rather than independently verified statistics. Citation metrics measure particular aspects of scholarly attention and should be interpreted alongside research quality, methodological rigor, reproducibility, and practical relevance.

Award Suitability

The research themes and supplied publication record provide relevant material for consideration in an academic recognition process associated with the International Academic Excellence Awards. A fair assessment should consider verified publications, individual contributions, research quality, and documented impact. This profile does not establish that an award has been granted or that editorial board membership has been independently confirmed.

Conclusion

Pourya Gholizadeh’s selected publications cover important questions in antimicrobial resistance, oral microbiology, and microbial pathogenesis. Together, these topics illustrate connections between fundamental microbiological research and clinical challenges. Verification of bibliographic records, institutional affiliation, research metrics, and editorial role will strengthen the accuracy and reliability of this academic recognition profile.

References

  1. Google Scholar. (n.d.). Pourya Gholizadeh: author profile and publication records. https://scholar.google.com/citations?user=1XSHxVkAAAAJ&hl=en
  2. Gholizadeh, P., Eslami, H., Yousefi, M., et al. (2016). Role of oral microbiome on oral cancers, a review. Biomedicine & Pharmacotherapy, 84, 552–558. Publication record: Google Scholar record. DOI not independently verified.
  3. Aghapour, Z., Gholizadeh, P., Ganbarov, K., et al. (2019). Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infection and Drug Resistance, 965–975. Publication record: Google Scholar record. DOI not independently verified.
  4. Gholizadeh, P., Eslami, H., & Kafil, H. S. (2017). Carcinogenesis mechanisms of Fusobacterium nucleatum. Biomedicine & Pharmacotherapy, 89, 918–925. Publication record. DOI not independently verified.
  5. Gholizadeh, P., Köse, Ş., Dao, S., et al. (2020). How CRISPR-Cas system could be used to combat antimicrobial resistance. Infection and Drug Resistance, 1111–1121. Publication record. DOI not independently verified.
  6. Gholizadeh, P., Pormohammad, A., Eslami, H., et al. (2017). Oral pathogenesis of Aggregatibacter actinomycetemcomitans. Microbial Pathogenesis, 113, 303–311. Publication record. DOI not independently verified.
  7. International Academic Excellence Awards. (n.d.). Official award website. https://academicexcellenceawards.com/